199 related articles for article (PubMed ID: 22625418)
1. Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.
Grimaldi C; Capasso A
Mini Rev Med Chem; 2012 Oct; 12(11):1119-26. PubMed ID: 22625418
[TBL] [Abstract][Full Text] [Related]
2. Lipid rafts: a nexus for endocannabinoid signaling?
McFarland MJ; Barker EL
Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
[TBL] [Abstract][Full Text] [Related]
3. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.
Barnett-Norris J; Lynch D; Reggio PH
Life Sci; 2005 Aug; 77(14):1625-39. PubMed ID: 15993425
[TBL] [Abstract][Full Text] [Related]
4. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
Quest AF; Leyton L; Párraga M
Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cholesterol trafficking and signaling in rafts and caveolae.
Fielding CJ; Fielding PE
Biochim Biophys Acta; 2003 Mar; 1610(2):219-28. PubMed ID: 12648776
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.
Chen W; Jump DB; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):18-26. PubMed ID: 17197511
[TBL] [Abstract][Full Text] [Related]
7. Lipid rafts, caveolae and GPI-linked proteins.
Reeves VL; Thomas CM; Smart EJ
Adv Exp Med Biol; 2012; 729():3-13. PubMed ID: 22411310
[TBL] [Abstract][Full Text] [Related]
8. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
McFarland MJ; Terebova EA; Barker EL
AAPS J; 2006 Mar; 8(1):E95-100. PubMed ID: 16584138
[TBL] [Abstract][Full Text] [Related]
9. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
Chini B; Parenti M
J Mol Endocrinol; 2004 Apr; 32(2):325-38. PubMed ID: 15072542
[TBL] [Abstract][Full Text] [Related]
10. Methods for the study of signaling molecules in membrane lipid rafts and caveolae.
Ostrom RS; Insel PA
Methods Mol Biol; 2006; 332():181-91. PubMed ID: 16878693
[TBL] [Abstract][Full Text] [Related]
11. Effect of sterol carrier protein-2 expression on sphingolipid distribution in plasma membrane lipid rafts/caveolae.
Atshaves BP; Jefferson JR; McIntosh AL; Gallegos A; McCann BM; Landrock KK; Kier AB; Schroeder F
Lipids; 2007 Oct; 42(10):871-84. PubMed ID: 17680294
[TBL] [Abstract][Full Text] [Related]
12. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.
Patel HH; Murray F; Insel PA
Handb Exp Pharmacol; 2008; (186):167-84. PubMed ID: 18491052
[TBL] [Abstract][Full Text] [Related]
13. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
14. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids.
Cheng ZJ; Singh RD; Marks DL; Pagano RE
Mol Membr Biol; 2006; 23(1):101-10. PubMed ID: 16611585
[TBL] [Abstract][Full Text] [Related]
15. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains.
Anderson RG; Jacobson K
Science; 2002 Jun; 296(5574):1821-5. PubMed ID: 12052946
[TBL] [Abstract][Full Text] [Related]
16. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
Liao YS; Wu J; Wang P; Zhang H
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
[TBL] [Abstract][Full Text] [Related]
17. Caveolae and signalling in cancer.
Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Nat Rev Cancer; 2015 Apr; 15(4):225-37. PubMed ID: 25801618
[TBL] [Abstract][Full Text] [Related]
18. Growth factor receptors, lipid rafts and caveolae: an evolving story.
Pike LJ
Biochim Biophys Acta; 2005 Dec; 1746(3):260-73. PubMed ID: 15951036
[TBL] [Abstract][Full Text] [Related]
19. GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors.
Gasperi V; Dainese E; Oddi S; Sabatucci A; Maccarrone M
Curr Med Chem; 2013; 20(1):64-78. PubMed ID: 23151004
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
